CMS UPDATE: Public commenting of quality measures is temporarily unavailable, as NQF will no longer serve as the consensus-based entity for the Centers for Medicare & Medicaid Services (CMS) as of March 26, 2023.

NQF is working with CMS and the successor contractor to make a smooth transition of the endorsement and maintenance work, which will include further communication to stakeholders regarding this body of work, including public commenting for the fall 2022 measures, after March 26. Thank you for your patience and understanding.

Effective March 27, 2023, NQF is no longer the contracted consensus-based entity (CBE) for the Centers for Medicare & Medicaid Services (CMS). Battelle will serve as the CMS CBE for the endorsement & maintenance of quality performance measures. Materials posted to this site prior to the fall 2022 measure endorsement cycle will continue to be available to the public. However, any materials for the fall 2022 cycle and beyond can be found on the Battelle Partnership for Quality Measurement (PQM) website. Click here https://p4qm.org/ for more information.

 Read more

Description

The Opportunity

Renal disease is a leading cause of morbidity and mortality in the United States. More than 20 million adults in the United States (10 percent of the population) have chronic kidney disease (CKD). It is associated with premature mortality, decreased quality of life, and increased healthcare costs. Risk factors for CKD include cardiovascular disease, diabetes, hypertension, and obesity.1 Untreated CKD can result in end-stage renal disease (ESRD). Currently, over half a million people in the United States have received a diagnosis of ESRD.

In 1972, President Richard Nixon signed section 2991 of Public Law 92-603, which established ESRD as the only healthcare condition to be covered under Medicare for people under the age of 65.2 People are eligible for Medicare regardless of their age if their kidneys are no longer functioning, if they need regular dialysis, or if they have had a kidney transplant. Considering the high mortality rates and high healthcare utilization and costs associated with ESRD, the need to focus on quality measures for patients with renal disease is particularly important.

NQF Related Work

Stay Connected

For more information, please contact renal@qualityforum.org.



1 U.S. Renal Data System(USRDS). USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010. Available at http://www.usrds.org/atlas.htm. Last accessed June 2016.

2 CROWNWeb. CROWNWeb: History, Purpose, and Usage [video]. http://mycrownweb.org/help/what_is_crownweb/. Last accessed December 2015.

CMS UPDATE: Public commenting of quality measures is temporarily unavailable, as NQF will no longer serve as the consensus-based entity for the Centers for Medicare & Medicaid Services (CMS) as of March 26, 2023.

NQF is working with CMS and the successor contractor to make a smooth transition of the endorsement and maintenance work, which will include further communication to stakeholders regarding this body of work, including public commenting for the fall 2022 measures, after March 26. Thank you for your patience and understanding.

Effective March 27, 2023, NQF is no longer the contracted consensus-based entity (CBE) for the Centers for Medicare & Medicaid Services (CMS). Battelle will serve as the CMS CBE for the endorsement & maintenance of quality performance measures. Materials posted to this site prior to the fall 2022 measure endorsement cycle will continue to be available to the public. However, any materials for the fall 2022 cycle and beyond can be found on the Battelle Partnership for Quality Measurement (PQM) website. Click here https://p4qm.org/ for more information.

 Read more

Sign up for project alert emails that will help you stay informed with our latest project activities. 

Subscribe Now

Sign up for project alert emails that will help you stay informed with our latest project activities. 

Subscribe Now

Loading...